Head-To-Head Comparison: CardioGenics (OTCMKTS:CGNH) and FiscalNote (NYSE:NOTE)

FiscalNote (NYSE:NOTE) and CardioGenics (OTCMKTS:CGNH) are both business services companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

Valuation and Earnings

This table compares FiscalNote and CardioGenics’ gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FiscalNote	$129.63 million	1.30	-$115.46 million	($0.36)	-3.47
CardioGenics	N/A	N/A	N/A	N/A	N/A

CardioGenics has lower revenue, but higher earnings than FiscalNote.

Profitability

This table compares FiscalNote and CardioGenics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
FiscalNote	-48.89%	-141.98%	-29.90%
CardioGenics	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations and price targets for FiscalNote and CardioGenics, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FiscalNote	0	2	2	0	2.50
CardioGenics	0	0	0	0	N/A

FiscalNote currently has a consensus target price of $2.68, suggesting a potential upside of 114.67%.

Volatility and Risk

FiscalNote has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, CardioGenics has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500.

Insider and Institutional Ownership

54.3% of FiscalNote shares are owned by institutional investors. 47.6% of FiscalNote shares are owned by insiders. Comparatively, 41.4% of CardioGenics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

About FiscalNote

FiscalNote Holdings, Inc. operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. The company also delivers that intelligence through its suite of public policy and issues management products, as well as powerful tools to manage workflows, advocacy campaigns, and constituent relationships. It serves a customer base that includes businesses comprising the Fortune 100 companies, government agencies, law firms, professional services organizations, trade groups, and non-profits. FiscalNote Holdings, Inc. is headquartered in Washington, District Of Columbia.

About CardioGenics

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.